In the latest trading session, 2.59 million Bausch Health Companies Inc. (NYSE:BHC) shares changed hands as the company’s beta touched 0.98. With the company’s most recent per share price at $7.70 changed hands at -$0.67 or -7.98% at last look, the market valuation stands at $2.86B. BHC’s current price is a discount, trading about -32.86% off its 52-week high of $10.23. The share price had its 52-week low at $5.57, which suggests the last value was 27.66% up since then. When we look at Bausch Health Companies Inc.’s average trading volume, we note the 10-day average is 2.32 million shares, with the 3-month average coming to 2.48 million.
Analysts gave the Bausch Health Companies Inc. (BHC) stock a consensus recommendation rating of a Hold, calculated at a mean rating of 3.00. If we narrow down to specifics, the data shows that 0 out of 7 analysts rate the stock as a Sell, with a further 0 assigning it an Overweight rating. Of the remaining, 5 recommended BHC as a Hold, 1 felt it is a Buy and 1 rated the stock as Underweight. Bausch Health Companies Inc.’s EPS for the current quarter is expected to be $0.92.
In today's chaotic marketplace, the biggest gains will come from some currently-small companies that pass by older, larger businesses still stuck in a pre-pandemic world. The trick is figuring out which small caps will be tomorrow's winners. That's why StockWire News has put together a special Wealth Building Report, highlighting 3 small cap stocks set to soar in 2023.
Click here for full details and to join for free
Bausch Health Companies Inc. (NYSE:BHC) trade information
Instantly BHC was in red as seen in intraday trades today. With action -10.13%, the performance over the past five days has been red. The drop to weekly highs of 8.79 on Monday, 09/18/23 subtracted -7.98% to the stock’s daily price. The company’s shares are showing year-to-date upside of 22.64%, with the 5-day performance at -10.13% in the red. However, in the 30-day time frame, Bausch Health Companies Inc. (NYSE:BHC) is -7.76% down. Looking at the short shares, we see there were 24.7 million shares sold at short interest cover period of 8.61 days.
The consensus price target for the stock as assigned by Wall Street analysts is $8.50, meaning bulls need an upside of 9.41% from its recent market value. According to analyst projections, BHC’s forecast low is $6.00 with $12.00 as the target high. To hit the forecast high, the stock’s price needs a -55.84% plunge from its current level, while the stock would need to tank 22.08% for it to hit the projected low.
Bausch Health Companies Inc. (BHC) estimates and forecasts
Data shows that the Bausch Health Companies Inc. share is performing relatively much not better than most of its peers within the same industry. As can be gleaned from the statistics, the company’s share value shot 1.21% over the past 6 months, a 7.52% in annual growth rate that is considerably lower than the industry average of 10.10%. Moreover, analysts have looked to higher expectations by upgrading its fiscal year 2023 revenue estimates. The rating firms predict current quarter revenue for Bausch Health Companies Inc. will rise 21.10%, while the growth in revenue is estimated to hit 3.90% for the next quarter. Year-over-year growth is forecast to reach 3.60% up from the last financial year.
Consensus estimates given by 5 financial analysts project the company’s revenue in the current quarter to hit an average of $2.15 billion. 5 analysts are of the opinion that Bausch Health Companies Inc.’s revenue for the quarter ending Dec 2023 will be $2.26 billion. The company’s revenue for the corresponding quarters a year ago was $2.06 billion and $2.19 billion respectively. According to analysts, the company will likely register a growth in its current quarter sales, forecast at 4.30%. The estimates for the next quarter sales put growth at 2.90%.
Looking at the company’s year-on-year earnings, data shows that the past 5-year has an earnings growth rate of -16.60%. The 2023 estimates are for Bausch Health Companies Inc. earnings to increase by 76.50%, but the outlook for the next 5-year period is at 2.60% per year.
BHC Dividends
Bausch Health Companies Inc. is expected to release its next quarterly earnings report between November 01 and November 06.
Bausch Health Companies Inc. (NYSE:BHC)’s Major holders
If we look at who the major shareholders are, we find that insiders hold 7.86% of Bausch Health Companies Inc. shares while 74.12% of the shares are in the hands of institutional holders. The share float percentage for the stock currently stands at 80.44%. There are 74.12% institutions holding the Bausch Health Companies Inc. stock share, with Icahn Carl C the top institutional holder. As of Jun 29, 2023, the company held 9.62% of the shares, roughly 34.72 million BHC shares worth $277.77 million.
Paulson & Company, Inc. holds the second largest percentage of outstanding shares, with 7.32% or 26.44 million shares worth $211.51 million as of Jun 29, 2023.
Among Mutual Funds, the top two as of Jun 29, 2023 were Franklin Custodian Funds-Income Fund and Vanguard International Stock Index-Total Intl Stock Indx. With 15.0 million shares estimated at $120.0 million under it, the former controlled 4.16% of total outstanding shares. On the other hand, Vanguard International Stock Index-Total Intl Stock Indx held about 1.16% of the shares, roughly 4.19 million shares worth around $30.89 million.
- Tags: Bausch Health Companies Inc., BHC, BHC stock, NYSE:BHC
